DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on December 15, 2006; DOI: 10.1124/dmd.106.011429


0090-9556/07/3503-331-334$20.00
DMD 35:331-334, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.011429v1
35/3/331    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yan-Fei, X.
Right arrow Articles by Yong-Xiang, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yan-Fei, X.
Right arrow Articles by Yong-Xiang, W.
SHORT COMMUNICATION

Inhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious Rats

Xin Yan-Fei, Zhou Xiang-Jun, Lu Jie, and Wang Yong-Xiang

Laboratory of Molecular Pharmacology, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China

NG-nitro-arginine (NNA) is known to exhibit stereoselective pharmacokinetics in which NG-nitro-D-arginine (D-NNA) has a faster clearance rate than NG-nitro-L-arginine (L-NNA) in anesthetized rats, and D-NNA undergoes unidirectional chiral inversion. It was postulated that chiral inversion of D-NNA was performed in a two-step pathway by D-amino acid oxidase (DAAO) followed by an unidentified transaminase. Such chiral inversion contributes (at least partially) to the pharmacokinetic stereoselectivity of NNA. This study used the selective inhibitor of DAAO, sodium benzoate, to test the above hypothesis. An i.v. bolus injection of D-NNA (32 mg/kg) and L-NNA (16 mg/kg) in conscious rats exhibited biphasic disposition with different pharmacokinetic parameters in a stereospecific manner (approximately 5–10-fold differences). Unidirectional chiral inversion of D-NNA but not L-NNA was found from these animals. In addition to its similar inhibitory effects on the D-NNA conversion and DAAO activity in kidney homogenates, sodium benzoate completely blocked chiral inversion of D-NNA and led to a smaller stereospecific difference, reflected by a nearly 50% reduction of D-NNA clearance and a 2-fold increase in t1/2 and area under the curve of D-NNA in benzoate-pretreated rats. The results suggest that DAAO plays an essential role in chiral inversion of D-NNA and chiral inversion contributes mostly to the pharmacokinetic stereospecificity of NNA.


Address correspondence to: Yong-Xiang Wang, Laboratory of Systems Pharmacology, School of Pharmacy, Shanghai Jiao Tong University, Biology Building No. 6 (Room 102), 800 Dongchuan Road, Shanghai 200240, China. E-mail: yxwang{at}sjtu.edu.cn







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.